drugset / Trial / NCT01938534

Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use

NCT01938534 ↗

Phase 4 Unknown 440 enrolled Ajou University School of Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective study : Helicobacter pylori eradication therapy in accordance with past antibiotics use.

Timeline

Start
2013-09
Primary completion
2014-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg —
Subject Bismuth Potassium Citrate Unknown 600 mg —
Subject Clarithromycin Small molecule 500 mg —
Subject Metronidazole Small molecule 500 mg —
Subject Omeprazole Other / unclassified 30 mg —
Subject Tetracycline Unknown 500 mg —

Indications

No indication recorded.